Misoprostol in patients taking non-steroidalanti-inflammatory drugs

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7034.846a (Published 30 March 1996) Cite this as: BMJ 1996;312:846

Analysis excluded important events

  1. M J Shield,
  2. S V Morant
  1. Medical director Manager of biometrics Searle, PO Box 53, High Wycombe HP12 4HL

    EDITOR,—N Maiden and R Madhok's editorial1 highlights the rough halving of the incidence of serious gastrointestinal complications associated with non-steroidal anti-inflammatory drugs that was achieved with coadministration of misoprostol in a recent trial in almost 9000 patients.2 The authors point out the relevance of these results to clinical practice by adopting the valuable “numbers needed to treat” approach advocated by Cook and Sackett.3 They do not, however, take into account that the study's statistical power was based on the overall …

    View Full Text

    Sign in

    Log in through your institution